Webinar Presentations are Available Here.
| April 20 and April 21, 2021 11 am – 1:25 pm EDT 5 pm – 7 pm CET |
| The in-person Cell Culture Engineering XVII Conference has been postponed. To highlight the key role that the CCE community plays to free people worldwide from the shackles of the COVID-19 pandemic, we are planning two webinars during the original dates of the conference. The first Webinar will focus on Vaccines which are a key part of the strategy to defeat the COVID 19 pandemic. In general, a successful COVID vaccine must be safe and efficacious with a low cost of goods, the ability to be manufactured at a scale of hundreds of millions of doses, and able to be distributed worldwide. The second Webinar will focus on Therapeutic approaches to neutralizing the COVID 19 virus using antibodies and other Biologics. This will result in successful treatments with the goal of bringing these to market as rapidly as possible. We hope you will find the webinar programs of interest and encourage you to register. Tim Charlebois (Pfizer), Gargi Maheshwari (BMS), Jamey Young (Vanderbilt University). |
CCE Covid-19 Vaccines Webinar
APRIL 20 2021
11 am – 1:30 pm EDT
5 pm – 7 pm CET
Webinar Co-Chairs
Gargi Maheshwari
Barry Buckland
Alexander (Sandy) Douglas
(Oxford University, UK)
Raghavan Venkat
(AstraZeneca, USA)
11:10 – 11:45
“Development and Manufacturing of a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needs”
Trent Munro
(University of Queensland, Australia)
“Developing protein based subunit
vaccines as a rapid pandemic
response – are they fast enough?”
11:45 – 12:15
Ingrid Kromann
(CEPI, UK)
“CMC initiatives to secure global access for vaccines”
12:15 – 12:45
Wrap-up: 12:45 – 1:00
CCE Antibodies for Covid 19 Treatments Webinar
APRIL 21, 2021
11 am TO 1:30 pm EDT
5 pm – 7:30 pm CET
Webinars Co-Chairs
Tim Charlebois
Jamey Young
Bo Barnhart
(AbCellera, Canada)
“Combating COVID-19: Identifying
a potential drug candidate for human
testing in 90 days”
11:50 am – 12:20 pm
Kristen Douglas
(Vir Biotechnology, USA)
“Delivering therapeutic mAbs
for covid-19:
What can be done in just one year?”
12:20 pm – 12:50 pm
Weichang Zhou
(WuXi Biologics, China)
“From DNAs to INDs in 3- 6 months
for COVID-19 neutralizing antibodies”
12:50 pm – 1:20 pm
Mark Denison
(Vanderbilt University, USA)
“SARS-CoV-2 replication and targets for countermeasures”